Predicting outcome in patients with anti-GBM glomerulonephritis
Files
Publication date
2018-01-06
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Background and objectives Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. Design, setting, participants, &measurements This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. Results The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P˂ 0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. Inmultivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. Conclusions Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007.
Keywords
ANCA, Anti-GBM disease, Antibodies antineutrophil, Antiglomerular basement membrane antibody, Autoantibodies, Biopsy, Confidence intervals, Cytoplasmic, Follow-Up studies, Glomerular basement membrane, Glomerulonephritis, Goodpasture-s syndrome, Kidney, Kidney biopsy, Kidney failure chronic, Multivariate analysis, Regression analysis, Renal dialysis, Retrospective studies, Survival rate, Taverne, Epidemiology, Critical Care and Intensive Care Medicine, Nephrology, Transplantation
Citation
van Daalen, E, Jennette, J C, McAdoo, S P, Pusey, C D, Alba, M A, Poulton, C J, Wolterbeek, R, Nguyen, T Q, Goldschmeding, R, Alchi, B, Griffiths, M, de Zoysa, J R, Vincent, B, Bruijn, J A & Bajema, I M 2018, 'Predicting outcome in patients with anti-GBM glomerulonephritis', Clinical Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 63-72. https://doi.org/10.2215/CJN.04290417